EPIC Neuro, Inc.

The Institute for Molecular Medicine is an organization based in Huntington Beach, California, dedicated to advancing research in the field of molecular medicine. Although their online presence is currently inactive due to domain issues, the institute has been recognized for its contributions to scientific inquiry and innovation. Focused on the intersection of molecular biology and medical science, the Institute aims to foster a deeper understanding of various health conditions. Its research initiatives have aimed to explore potential therapeutic approaches and solutions for complex medical challenges. Generated from the website

Edwards Lifesciences is one of the world s leaders in advanced cardiovascular disease treatments. The company leverages its research, design, development and marketing expertise to produce products that addresses specific cardiovascular opportunities, including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz. The company has more than 5,000 employees throughout the world. It has manufacturing plants in the U.S., Brazil, Dominican Republic, Japan, Switzerland and Puerto Rico. Edwards Lifesciences is headquartered in Irvine, Calif.

Cerenetex is a pioneering company focused on the objective diagnosis of Large Vessel Occlusion (LVO) ischemic strokes, aiming to minimize delays in care and reduce brain injury for affected patients. By integrating advanced technology with traditional neurological assessments, Cerenetex enhances the accuracy of patient triaging and expedites treatment pathways. Strokes affect approximately 15 million individuals worldwide each year, making timely diagnosis and treatment critical to reducing misdiagnosis and improving patient outcomes. Cerenetex is dedicated to addressing these challenges, positioning itself at the forefront of stroke diagnosis innovation. Generated from the website